[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354871-105":59,"doc-detail-354871-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multiomic-profiling-of-er-positive-her2-negative-breast-cancer-reveals-markers-associated-with-metastatic-spread","Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread","","Metastatic breast cancer drives most disease-related deaths, yet metastasis prediction remains difficult in the estrogen receptor (ER)-positive, HER2-negative population. This study integrates tumor proteome and phosphoproteome profiling with matched transcriptome data to uncover new molecular subtypes and features tied to both lymph node and distant metastases. Using label-free DIA LC–MS/MS across 182 primary tumors, it quantifies thousands of proteins, identifies subtype-specific immune patterns, and links specific protein phosphorylation or heat shock protein 90 family members to survival outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multiomic-profiling-of-er-positive-her2-negative-breast-cancer-reveals-markers-associated-with-metastatic-spread/354871/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multiomic-profiling-of-er-positive-her2-negative-breast-cancer-reveals-markers-associated-with-metastatic-spread/354871.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is predicting metastasis challenging for ER-positive HER2-negative breast cancer?","Question",{"text":112,"@type":113},"Metastatic risk is difficult to forecast, particularly in the large and heterogeneous ER-positive/HER2-negative group. Existing markers remain insufficient for reliable stratification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What multiomic methods were used to profile the tumors?",{"text":117,"@type":113},"The study developed label-free proteome and phosphoproteome profiling using DIA LC–MS/MS and integrated the resulting data with parallel transcriptome profiling for 182 primary tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecular markers were associated with metastatic spread and patient survival?",{"text":121,"@type":113},"For lymph node metastasis, phosphorylated ES8L2 serine at position 570 correlated with improved recurrence-free survival. For distant metastases, proteins in the heat shock protein 90 family were linked to worse distant recurrence-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354871,1790177213,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Mosquim Junior et al. Breast Cancer Research (2026) 28:12 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-025-02173-9](https://doi.org/10.1186/s13058-025-02173-9)  \nRESEARCH Open Access  \nMultiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread  \nSergio Mosquim Junior1,2, Måns Zamore1, Johan Vallon-Christersson2, Lisa Rydén3,4 and Fredrik Levander1,5*  \nAbstract  \nBackground Metastatic disease is the main cause of breast cancer (BC)-related deaths, but prediction of metastases remains challenging especially in the large and diverse group with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative tumors. Molecular tumor features beyond currently used markers could provide important information for stratifying metastatic risk. To allow for the discovery of new subtypes and molecular tumor features associated with metastatic spread, i. e., both lymph node and distant metastases, we here leverage advances in proteomic profiling of tumors.  \nMethods We developed a protocol for proteome and phosphoproteome analysis using label-free data independent acquisition (DIA) liquid chromatography tandem mass spectrometry (LC–MS/MS) and integrated the generated data with parallel transcriptome data for the profiling of 182 ER-positive, HER2-negative primary BC tumors from the SCAN-B cohort.  \nResults A total of 13,571 protein groups, 7107 phosphopeptides and 13,085 expressed genes were quantified in at least 70% of the samples. The data showed clear differences between invasive lobular carcinoma and no special type cancers, including the hallmark loss of E-cadherin expression and differences in catenin levels. We identified potential new subtypes with differential immune infiltration patterns and survival through unsupervised consensus clustering. Additionally, by adopting an integrative, multiomic data analysis workflow, we identified several potential protein markers of both lymph node and distant metastases. For lymph node metastasis, the level of phosphorylated ES8L2 serine at position 570 (multivariable p value = 0 . 05, HR = 0 . 61, 95% CI 0.38–0. 99) was associated with improved recurrence-free survival, and showed decreased abundance in lymph node positive cases. For distant metastases, on the other hand, proteins belonging to the heat shock protein 90 family were associated with worse distant recurrence-free survival (multivariable p value = 0 . 0058, HR = 2 . 10, 95% CI 1.24–3. 55), with significantly higher abundance levels in patients with a distant recurrence event. These correlations with survival could also be validated in multiple external cohorts.  \nConclusions In summary, we present the most comprehensive matched multiomic dataset from ER-positive/HER2-negative BC tumors, not only serving as an invaluable resource for further advancing precision medicine but also allowing the discovery of potential biomarkers and providing unique insights into metastatic processes.  \n*Correspondence:  \nFredrik Levander [fredrik.levander@immun.lth.se](fredrik.levander@immun.lth.se)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a cop","cbCaio4sAosuCkG2","https://ap.wps.com/l/cbCaio4sAosuCkG2","pdf",2466139,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Epidemiology and screening\n## Metastasis and prognostic role of lymph nodes\n## Molecular profiling and biomarker challenges\n## Role of proteins and proteomics","[{\"question\":\"Why is predicting metastasis challenging for ER-positive HER2-negative breast cancer?\",\"answer\":\"Metastatic risk is difficult to forecast, particularly in the large and heterogeneous ER-positive/HER2-negative group. Existing markers remain insufficient for reliable stratification.\"},{\"question\":\"What multiomic methods were used to profile the tumors?\",\"answer\":\"The study developed label-free proteome and phosphoproteome profiling using DIA LC–MS/MS and integrated the resulting data with parallel transcriptome profiling for 182 primary tumors.\"},{\"question\":\"Which molecular markers were associated with metastatic spread and patient survival?\",\"answer\":\"For lymph node metastasis, phosphorylated ES8L2 serine at position 570 correlated with improved recurrence-free survival. For distant metastases, proteins in the heat shock protein 90 family were linked to worse distant recurrence-free survival.\"}]","Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread | PDF",1790114546,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c26c706eeb79150c14eeaadf72dbcc11.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/848f6c9a6547160e796b64a2050f2891.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d785f3803d3dfcad2a8248219e97a7b.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fd6b419bb1f83e2871f878d5d84f271.webp",980,1306]